3. Stages
1) Initiation
* Caused by mutation following application of initiating agent
* Once mutation is fixed by mitosis, it is irreversible
* Cells histologically appear normal inspite of genetic damage
* Initiated cells are also diploid, with normal DNA content
* Initiator
- Chemical e.g. smoking & alcohol) or
- Radiation (e.g. solar ultraviolet irradiation)
4. 2) Promotion
* Characterized by cell proliferation (clonal expansion), &
reversible after cassation of promoting agent
* Promoting agents act through increase in growth factor which
stimulate cell proliferation through epigenetic mechanism
* Histologically, pre-neoplastic lesion in form of dysplasia or
benign tumor
* Promoted cells are usually diploid
6. 3) Progression
* Results from multiple, mutations in proliferating cellular
subclones which results in intratumor molecular heterogeneity
* Irreversible process
* Histologically: cellular anaplasia, other malignant biological
feature, cells are aneuploid
7. Initiation Promotion Progression
Sequence First Second Third
Biology Mutation
Clonal
expansion
Clonal
evolution
Ploidy Diploid Diploid Aneuploid
Reversibility Irreversible Reversible Irreversible
Histology Unremarkable
Precancerous
lesion
Malignant
tumor
8. Multihit Carcinogenesis
Proposed by: Vogelstein after extensive genetic & pathologic
studies on adenoma carcinoma sequence in colon
State
* Cancer develops as result of accumulation of multiple genetic
lesions involving activation of proto-oncogenes & loss of tumor
suppressor genes
* Mutation of at least 4 to 5 genes are necessary for formation of
truly malignant tumor
* Total accumulation of genetic lesions, rather than their order of
sequence, which is most critical in cancer development (multihit
rather than multistep process)
9.
10. Monoclonality of Cancer
Cancer arises through multistep accumulation of somatic gene
mutations in progeny of single cell of origin (monoclonal)
Accumulation of mutations in different subclones will ultimately
lead to molecular intratumour heterogeneity
Tumour cell subclones, compete with each other on basis of growth
rate, with ultimate survival & predominance of more aggressive
subclones (clonal evolution)
Two driving forces of malignancy are mutagenesis & mitogenesis
11. Monoclonal, or single cell, origin of cancer is supported by two,
histochemical observations in malignant tumours:
* G6PD isoenzyme: normal cells contain two isoenzymes (A &
B) of enzyme glucose 6-phDsphate dehydrogenase (G6PD).
Whereas, malignant tumours which arise from these normal
tissue contain only one, isoenzyme, either A, or B, hence
confirming monoclonal origin of tumor
* Light chain restriction: normal B lymphocytes carry on their
surface immunoglobulin with two types of light chain